oxonic acid has been researched along with Leukemia, Myelogenous, Chronic, BCR-ABL Positive in 3 studies
Oxonic Acid: Antagonist of urate oxidase.
Leukemia, Myelogenous, Chronic, BCR-ABL Positive: Clonal hematopoetic disorder caused by an acquired genetic defect in PLURIPOTENT STEM CELLS. It starts in MYELOID CELLS of the bone marrow, invades the blood and then other organs. The condition progresses from a stable, more indolent, chronic phase (LEUKEMIA, MYELOID, CHRONIC PHASE) lasting up to 7 years, to an advanced phase composed of an accelerated phase (LEUKEMIA, MYELOID, ACCELERATED PHASE) and BLAST CRISIS.
| Excerpt | Relevance | Reference |
|---|---|---|
| "He had no evidence of recurrence of gastric cancer, although he had a continuous poor appetite due to TS-1." | 1.36 | [Secondary chronic myelogenous leukemia following postoperative TS-1 therapy for advanced gastric cancer]. ( Imai, T; Machida, T; Shima, Y; Uemura, Y, 2010) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Sueda, T | 1 |
| Kudo, T | 1 |
| Sakai, D | 1 |
| Uemura, M | 1 |
| Nishimura, J | 1 |
| Hata, T | 1 |
| Takemasa, I | 1 |
| Mizushima, T | 1 |
| Yamamoto, H | 1 |
| Ezoe, S | 1 |
| Matsumoto, K | 1 |
| Doki, Y | 1 |
| Mori, M | 1 |
| Satoh, T | 1 |
| Uemura, Y | 1 |
| Imai, T | 1 |
| Machida, T | 1 |
| Shima, Y | 1 |
| Higuchi, M | 1 |
| Nishinaka, H | 1 |
| Yamano, Y | 1 |
3 other studies available for oxonic acid and Leukemia, Myelogenous, Chronic, BCR-ABL Positive
| Article | Year |
|---|---|
Safety and pharmacokinetics of S-1 in a recurrent colon cancer patient with chronic myeloid leukemia treated with dasatinib: a case report.
Topics: Aged; Antimetabolites, Antineoplastic; Area Under Curve; Colonic Neoplasms; Dasatinib; Drug Combinat | 2014 |
[Secondary chronic myelogenous leukemia following postoperative TS-1 therapy for advanced gastric cancer].
Topics: Aged; Antimetabolites, Antineoplastic; Benzamides; Drug Combinations; Fatal Outcome; Gastrectomy; Hu | 2010 |
[A case of chronic myeloid leukemia following TS-1 therapy for advanced gastric cancer].
Topics: Antimetabolites, Antineoplastic; Antineoplastic Agents; Benzamides; Combined Modality Therapy; Drug | 2006 |